Table 1.
Serum glucose, insulin, C-peptide, HbA1c, AGEs and HO-1 levels.
Control | Diabetic (D) | D + AD-MSCs | D + BM-MSCs | |
---|---|---|---|---|
Glucose(mg/ 100 ml) | 93.91 ± 4.42 | 405.40 ± 16.46 a | 96.75 ± 5.70b | 150.50 ± 5.22abc |
Insulin (µ I U/ml) | 17.15 ± 0.66 | 8.02 ± 0.33a | 16.90 ± 0.34b | 13.32 ± 0.57abc |
C-peptide (ng/ml) | 0.84 ± 0.03 | 0.30 ± 0.03a | 0.81 ± 0.01b | 0.75 ± 0.02abc |
HbA1c (%) | 2.95 ± 0.11 | 5.90 ± 0.20a | 2.93 ± 0.14b | 3.49 ± 0.10abc |
AGEs (AU/mg protein) | 2.80 ± 0.11 | 8.46 ± 0.35a | 3.00 ± 0.16b | 4.12 ± 0.12abc |
HO-1 (P mol/mg) | 260.00 ± 13.53 | 87.00 ± 3.60 a | 264.66 ± 8.12b | 218.00 ± 9.04abc |
Values expressed as mean ± SEM (n = 6). a, b and c are Significant differences (P ≤ 0.05) comparing to control, diabetic and diabetic AD-MSCs treated groups respectively.